Should I Buy NCI? NCI 2026 Analysis

Should You Buy Neo-Concept International Group Holdings Ltd (NCI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.250

1 Day change

52 Week Range

3.400

Analysis Updated At

2026/01/30

NCI is not a good buy right now. The technical setup remains bearish (price still under key moving averages with weak momentum), there are no fresh news/catalysts to re-rate the stock, and Intellectia has no buy signals today. For an impatient buyer looking for immediate traction, this lacks a clear edge at the current pre-market price (~1.09).

Technical Analysis

Trend/Momentum: Bearish. The moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), implying the broader trend is down and rallies may face selling pressure. MACD histogram is negative (-0.00233) and still below zero (bearish), though the negative momentum is contracting (selling pressure may be easing but not reversed). RSI(6) at 42.65 is neutral-to-weak, not signaling an oversold bounce. Key levels (pre-market ~1.09): Pivot 1.113 is immediate overhead resistance; price is below pivot, which is a near-term negative. Support S1 1.027 then S2 0.974; resistance R1 1.199 then R2 1.252. Pattern-based near-term odds: Similar-pattern stats suggest modest expected moves (next day ~+0.22%, next week ~-0.55%, next month ~+2.13%) with only a 40% probability indicated—not a strong short-term setup. Intellectia Proprietary Trading Signals: - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

No news in the last week; no identifiable event-driven catalysts from the provided data. Momentum selling pressure is contracting (MACD histogram negatively contracting), which can sometimes precede stabilization.

Neutral/Negative Catalysts

and price is below the pivot (1.113), suggesting rallies may fail near resistance. No Intellectia buy signals (AI Stock Picker/SwingMax), and no recent news flow to drive an upside re-pricing. Broader market context is risk-off (S&P 500 pre-market -0.8%), which can weigh on small caps.

Financial Performance

Financial snapshot not available (error: list index out of range). Latest quarter/season and growth trends cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data provided, so recent Wall Street sentiment (pros/cons view) cannot be determined from this dataset. Trading trends show Hedge Funds: Neutral (no significant quarterly trend) and Insiders: Neutral (no significant monthly trend). Congress trading: no recent data available.

Analyst Rating

Wall Street analysts forecast NCI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCI is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.250

Low

Averages

High